/ 
/ 
Image:MonoclonalAb.jpg
From Wikipedia, the free encyclopedia
No higher resolution available.
MonoclonalAb.jpg (427 × 285 pixels, file size: 27 KB, MIME type: image/jpeg)
| This is a file from the Wikimedia Commons. The description on its description page there is shown below.
|
| Description |
English: Monoclonal antibodies for cancer. ADEPT, antibody directed enzyme prodrug therapy; ADCC, antibody dependent cell-mediated cytotoxicity; CDC, complement dependent cytotoxicity; MAb, monoclonal antibody; scFv, single-chain Fv fragment.
|
|---|---|
| Source |
Modified from
|
| Date |
2004-12-16 (original upload date) |
| Author |
Original uploader was Ramujana at en.wikipedia |
| Permission (Reusing this image) |
PD-AUTHOR; Released into the public domain (by the author). |
 A vector version of this image (SVG) is available.  Image:Monoclonal antibodies.svgFor more information about vector graphics, read about Commons transition to SVG. Deutsch | English | Español | Français | Galego | עברית | Magyar | Italiano | 日本語 | 한국어 | Lietuvių | Occitan | Polski | Português | Русский | Српски / Srpski | Svenska | Українська | +/- |
 |
[edit] License information
 |
This file has been (or is hereby) released into the public domain by its author, en:User:Ramujana. This applies worldwide.
In case this is not legally possible: Afrikaans | Anglo-Saxon | العربية | Беларуская | Беларуская (тарашкевіца) | Български | Česky | Словѣ́ньскъ / ⰔⰎⰑⰂⰡⰐⰠⰔⰍⰟ | Dansk | Deutsch | ދިވެހިބަސް | ཇོང་ཁ | Ελληνικά | English | Español | فارسی | Suomi | Français | Avañe'ẽ | Հայերեն | Italiano | 日本語 | 한국어 | Plattdüütsch | Nederlands | Norsk (bokmål) | ਪੰਜਾਬੀ | Polski | Português | Română | Русский | Svenska | தமிழ் | Türkçe | Українська | Volapük | 中文 | 中文(台灣) | 粵語 | +/- |
[edit] Original upload log
The original description page is/was here. All following user names refer to en.wikipedia.
- 2004-12-16 14:23 Ramujana 427×285×8 (27307 bytes) Monoclonal antibodies for cancer; Modified from Carter P: Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-129; {{CopyrightedFreeUse}}
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 06:51, 20 July 2008 | | 427×285 (27 KB) | Optigan13 | ({{Information |Description={{en|'''Monoclonal antibodies for cancer.''' ADEPT, antibody directed enzyme prodrug therapy; ADCC, antibody dependent cell-mediated cytotoxicity; CDC, complement dependent cytotoxicity; MAb, monoclonal antibody; scFv, single-ch) |
File links
More than 100 pages link to this file. The following list shows the first 100 page links to this file only. A full list is available.
- Monoclonal antibodies
- Basiliximab
- Gemtuzumab ozogamicin
- OKT3
- Efalizumab
- Palivizumab
- Monoclonal antibody therapy
- Panitumumab
- Apolizumab
- Bapineuzumab
- Ecromeximab
- Oregovomab
- Besilesomab
- Lemalesomab
- Sulesomab
- Denosumab
- Gavilimomab
- Afelimomab
- Faralimomab
- Catumaxomab
- Ertumaxomab
- Adecatumumab
- Altumomab
- Anatumomab mafenatox
- Arcitumomab
- Aselizumab
- Atorolimumab
- Bavituximab
- Bectumomab
- Bertilimumab
- Biciromab brallobarbital
- Bivatuzumab mertansine
- Cantuzumab mertansine
- Cedelizumab
- Ipilimumab
- Lerdelimumab
- Metelimumab
- Zanolimumab
- Zolimomab aritox
- Elsilimomab
- Inolimomab
- Odulimomab
- Vepalimomab
- Galiximab
- Gomiliximab
- Golimumab
- Maslimomab
- Keliximab
- Lumiliximab
- Teneliximab
- Vapaliximab
- Tremelimumab
- Erlizumab
- Fontolizumab
- Ocrelizumab
- Pascolizumab
- Pexelizumab
- Reslizumab
- Rovelizumab
- Ruplizumab
- Siplizumab
- Talizumab
- Tocilizumab
- Toralizumab
- Visilizumab
- Pemtumomab
- Mepolizumab
- Exbivirumab
- Libivirumab
- Sevirumab
- Tuvirumab
- Felvizumab
- Motavizumab
- Inotuzumab ozogamicin
- Lintuzumab
- Matuzumab
- Nimotuzumab
- Sibrotuzumab
- Tacatuzumab tetraxetan
- Tadocizumab
- Tefibazumab
- Tucotuzumab celmoleukin
- Epratuzumab
- Atlizumab
- Nerelimomab
- Urtoxazumab
- Pagibaximab
- Iratumumab
- Lexatumumab
- Mapatumumab
- Ofatumumab
- Pritumumab
- Zalutumumab
- Stamulumab
- Efungumab
- Raxibacumab
- Labetuzumab
- Capromab pendetide
- Detumomab
- Igovomab
View more links to this file.
